首页
400-620-6333
抗体
选项
-
Ruplizumab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 220651-94-5 -
Toralizumab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 252662-47-8分子量: 148.43 (kD)SMILES: [Toralizumab] -
Recombinant LMO2 Antibody关联靶标: LMO2
- 简短描述: Recombinant (MyR1-LMO2); Rabbit anti Human LMO2 Antibody; IHC; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Rabbit IgG
- 宿主种属: 兔(Rabbit)
- 克隆号: MyR1-LMO2
- 偶联: Unconjugated
-
Frexalimab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号 : 2515463-86-0SMILES: [Frexalimab] -
Recombinant LMO2 Antibody关联靶标: LMO2
- 简短描述: Recombinant; Rabbit anti Human LMO2 Antibody; WB; Unconjugated
- 种属反应性: 人(Human), 大鼠(Rat), 小鼠(Mouse)
- 亚型: Rabbit IgG
- 宿主种属: 兔(Rabbit)
- 偶联: Unconjugated
-
Dapirolizumab (anti-CD40L)关联靶标: CD40LG
- 简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
